Ranked by engagement
Top topics — all time page 29
Ranked by replies, likes and views over all time, with a bonus for topics that reached a marked solution. Engagement is a proxy for usefulness and a poor one; the documentation commons is the better index of what is settled.
1,535 topics · page 29 of 40
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Follow-up: The most useful thing you learned here that was not the answer you came for
On the subject in the title: The most useful thing you learned here that was not the answer you came for Working notes rather than a conclusion. Lower-stakes topic, but the sourcing rule still applies if…
|
+30 | 34 | 9.7k | 11h |
|
Revisiting: How this community labels and discusses unrefereed work
Revisiting: How this community labels and discusses unrefereed work Writing it up because I had to work it out twice and would rather nobody else did. I have seen SURMOUNT-OSA ( N Engl J Med , 2024) cited in…
|
+31 | 35 | 7k | 1d |
|
Amylin and gastric emptying: overlapping mechanisms with incretins
On the subject in the title: Amylin and gastric emptying: overlapping mechanisms with incretins Working notes rather than a conclusion. Session topic: STEP 2 ( Lancet , 2021). Please read it before posting;…
|
2 | 50k | 17mo | |
|
Why a preprint's supplementary material is often the best part
Why a preprint's supplementary material is often the best part I have a specific reason for asking rather than idle curiosity, and the context is below. Session topic: SUSTAIN 6 ( N Engl J Med , 2016). Please…
|
+38 | 42 | 863 | 22mo |
|
Follow-up: What a seizure notice actually says
What a seizure notice actually says — that is the question, and I have not found it answered plainly anywhere I have looked. Structured report rather than an opinion, following the format the maintainers…
|
+35 | 41 | 490 | 9mo |
|
Second pass at: Fasting versus non-fasting and which tests care
On the subject in the title: Second pass at: Fasting versus non-fasting and which tests care Working notes rather than a conclusion. General question, not a request for advice about my own care — I know the…
|
+20 | 25 | 21k | 3mo |
|
[2026 update] Whether protein timing matters at a large deficit
Whether protein timing matters at a large deficit — setting out what I have, and where I think it stops being reliable. Longitudinal report with the method stated, because a number without a method is not a…
|
+4 | 8 | 46k | 7mo |
|
Lipid changes during rapid weight loss: the expected trajectory
Posting this under the heading it deserves: Lipid changes during rapid weight loss: the expected trajectory Everything below is what sits behind that. General question, not a request for advice about my own…
|
+11 | 15 | 34k | 11h |
|
Bariatric surgery history: altered anatomy, altered expectations
Posting this under the heading it deserves: Bariatric surgery history: altered anatomy, altered expectations Everything below is what sits behind that. General question, not a request for advice about my own…
|
+35 | 39 | 486 | 2mo |
|
Coming back to: Feature request: should a dose-equivalence tool exist at all?
Feature request: should a dose-equivalence tool exist at all? I have a specific reason for asking rather than idle curiosity, and the context is below. Posting the method first, because I know what the first…
|
+37 | 41 | 725 | 7mo |
|
Second pass at: Reading a combination trial: attributing effect to components
Second pass at: Reading a combination trial: attributing effect to components — setting out what I have, and where I think it stops being reliable. I have seen SURMOUNT-2 ( Lancet , 2023) cited in support of…
|
+39 | 43 | 7.3k | 12mo |
|
Second pass at: Choosing a concentration on purpose rather than by accident
Second pass at: Choosing a concentration on purpose rather than by accident Writing it up because I had to work it out twice and would rather nobody else did. Practical question with the units stated, because…
|
+44 | 48 | 1k | 19mo |
|
The report format the maintainers ask for, and why each field is there — what changed since
The report format the maintainers ask for, and why each field is there — what changed since Writing it up because I had to work it out twice and would rather nobody else did. Structured report rather than an…
|
+29 | 35 | 6.6k | 13mo |
|
Solubility limits and what a cloudy solution is telling you
Solubility limits and what a cloudy solution is telling you — setting out what I have, and where I think it stops being reliable. A documentation question rather than an analytical one. I have a certificate…
|
+11 | 15 | 34k | 20h |
|
Needle changes between doses on a reusable pen
Posting this under the heading it deserves: Needle changes between doses on a reusable pen Everything below is what sits behind that. I have read the maintained page on this and I still have a gap, so I am…
|
+34 | 38 | 1.5k | 10mo |
|
Revisiting: Holding a dose indefinitely: is there a documented downside?
The question in the title: Revisiting: Holding a dose indefinitely: is there a documented downside? I will give what I have already checked below so nobody repeats it. A question about technique rather than…
|
+26 | 30 | 4.5k | 18mo |
|
A pen that felt like it delivered nothing: diagnosing it afterwards
On the subject in the title: A pen that felt like it delivered nothing: diagnosing it afterwards Working notes rather than a conclusion. A question about technique rather than about dose. I have been doing…
|
+35 | 39 | 584 | 6mo |
|
Revisiting: Aggregate verification data across the directory, with caveats
Revisiting: Aggregate verification data across the directory, with caveats — setting out what I have, and where I think it stops being reliable. I would like to talk about documentation quality as a signal,…
|
+22 | 26 | 23k | 17mo |
|
Coming back to: Official shortage notices and what they authorise
Official shortage notices and what they authorise — setting out what I have, and where I think it stops being reliable. A coverage question with the paperwork detail included, since that is what determines…
|
+39 | 43 | 510 | 17mo |
|
Measurement error in home scales, with a worked standard deviation
Measurement error in home scales, with a worked standard deviation Writing it up because I had to work it out twice and would rather nobody else did. Comparing SURPASS-4 ( Lancet , 2021) with STEP 1 ( N Engl…
|
+26 | 31 | 4.3k | 4mo |
|
Oral versus injectable exposure: comparing apples to a different fruit — a second dataset
Posting this under the heading it deserves: Oral versus injectable exposure: comparing apples to a different fruit — a second dataset Everything below is what sits behind that. Comparing STEP 8 ( JAMA , 2022)…
|
+27 | 31 | 17k | 25d |
|
Journal club: semaglutide in MASH, and surrogate endpoints
Posting this under the heading it deserves: Journal club: semaglutide in MASH, and surrogate endpoints Everything below is what sits behind that. Comparing SCALE ( N Engl J Med , 2015) with SURMOUNT-2 (…
|
+24 | 28 | 17k | 15h |
|
Injecting into an area that has become firm: why not to — does this still hold?
Asking directly, because I could not find a straight answer: Injecting into an area that has become firm: why not to — does this still hold? I have read the maintained page on this and I still have a gap, so…
|
2 | 49k | 9mo | |
|
A friction point in the promotion workflow — the long version
On the subject in the title: A friction point in the promotion workflow — the long version Working notes rather than a conclusion. Nominating something for promotion into the documentation commons. The topic…
|
+1 | 5 | 46k | 13mo |
|
Reaching a dose and staying there for a year: a longitudinal note — does this still hold?
Asking directly, because I could not find a straight answer: Reaching a dose and staying there for a year: a longitudinal note — does this still hold? I have read the maintained page on this and I still have…
|
+35 | 39 | 547 | 11mo |
|
Risk-of-bias tools and the judgement they conceal — does this still hold?
Risk-of-bias tools and the judgement they conceal — does this still hold? — that is the question, and I have not found it answered plainly anywhere I have looked. Comparing SURPASS-2 ( N Engl J Med , 2021)…
|
+26 | 30 | 5.8k | 23h |
|
The most common factual error about semaglutide on the internet
On the subject in the title: The most common factual error about semaglutide on the internet Working notes rather than a conclusion. Session topic: STEP 2 ( Lancet , 2021). Please read it before posting; the…
|
2 | 49k | 2y | |
|
Semaglutide formulation: what is in the licensed product besides the peptide
Semaglutide formulation: what is in the licensed product besides the peptide — setting out what I have, and where I think it stops being reliable. Comparing LEADER ( N Engl J Med , 2016) with SURMOUNT-1 ( N…
|
+29 | 35 | 4.4k | 1h |
|
Reading U-100 graduations, with a conversion table
Posting this under the heading it deserves: Reading U-100 graduations, with a conversion table Everything below is what sits behind that. Practical question with the units stated, because I have seen how…
|
+35 | 41 | 2k | 1d |
|
Choosing which test to pay for, given a fixed budget — does this still hold?
Choosing which test to pay for, given a fixed budget — does this still hold? I have a specific reason for asking rather than idle curiosity, and the context is below. I would like to talk about documentation…
|
+35 | 39 | 755 | 20mo |